Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · IEX Real-Time Price · USD
2.000
+0.050 (2.56%)
At close: May 24, 2024, 4:00 PM
1.940
-0.060 (-3.00%)
After-hours: May 24, 2024, 4:38 PM EDT

Alterity Therapeutics Statistics

Total Valuation

ATHE has a market cap or net worth of $17.48 million. The enterprise value is $9.32 million.

Market Cap 17.48M
Enterprise Value 9.32M

Important Dates

The next estimated earnings date is Tuesday, June 4, 2024, after market close.

Earnings Date Jun 4, 2024
Ex-Dividend Date n/a

Share Statistics

ATHE has 8.74 million shares outstanding.

Shares Outstanding 8.74M
Owned by Insiders (%) n/a
Owned by Institutions (%) 1.08%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.50
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.90, with zero debt.

Current Ratio 4.90
Quick Ratio 4.07
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -53.70% and return on invested capital (ROIC) is -95.16%.

Return on Equity (ROE) -53.70%
Return on Assets (ROA) -44.20%
Return on Capital (ROIC) -95.16%
Revenue Per Employee n/a
Profits Per Employee -$759,540
Employee Count 11
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, ATHE has paid $370 in taxes.

Income Tax 370
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -25.93% in the last 52 weeks. The beta is 0.72, so ATHE's price volatility has been lower than the market average.

Beta (1Y) 0.72
52-Week Price Change -25.93%
50-Day Moving Average 2.04
200-Day Moving Average 2.27
Relative Strength Index (RSI) 47.57
Average Volume (30 Days) 79,647

Short Selling Information

Short Interest 35,034
Short Previous Month 85,893
Short % of Shares Out 2.25%
Short % of Float n/a
Short Ratio (days to cover) 0.49

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -11.11M
Pretax Income -8.14M
Net Income -8.35M
EBITDA n/a
EBIT -8.14M
Earnings Per Share (EPS) -$2.27
Full Income Statement

Balance Sheet

The company has $8.16 million in cash and no debt, giving a net cash position of $8.16 million or $0.93 per share.

Cash & Cash Equivalents 8.16M
Total Debt n/a
Net Cash 8.16M
Net Cash Per Share $0.93
Equity / Book Value 11.68M
Book Value Per Share 1.34
Working Capital 11.59M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.68 million and capital expenditures -$5,403, giving a free cash flow of -$9.68 million.

Operating Cash Flow -9.68M
Capital Expenditures -5,403
Free Cash Flow -9.68M
FCF Per Share -$2.38
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ATHE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.08%
Shareholder Yield -17.08%
Earnings Yield -47.79%
FCF Yield -55.38%

Analyst Forecast

The average price target for ATHE is $7.00, which is 250.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.00
Price Target Difference 250.00%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 9, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date Jan 9, 2023
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score n/a